Congestive Heart Failure Pipeline Review: Ken Research

1
Congestive Heart Failure Pipeline Review Ken
Research
2
Global Markets Direct's latest Pharmaceutical and
Healthcare disease pipeline guide Congestive
Heart Failure (Heart Failure)-Pipeline Review, H1
2018, provides an overview of the Congestive
Heart Failure (Heart Failure) (Cardiovascular)
pipeline landscape. Heart failure is also known
as congestive heart failure (CHF). CHF is a
condition in which the heart is no longer able to
pump out enough oxygen-rich blood. Symptoms
include cough, fatigue, weakness, faintness, loss
of appetite, swollen (enlarged) liver or abdomen,
swollen feet and ankles and weight gain. There
are two types of heart failure including systolic
heart failure (left ventricle loses its ability
to contract normally) and diastolic heart failure
(left ventricle loses its ability to relax
normally). The predisposing factors include high
blood pressure, diabetes, sleep apnea, alcohol
use and irregular heartbeats. Treatment includes
surgery, vasodilator, beta blockers and
diuretics.
3
Global Markets Direct's Pharmaceutical and
Healthcare latest pipeline guide Congestive Heart
Failure (Heart Failure)-Pipeline Review, H1 2018,
provides comprehensive information on the
therapeutics under development for Congestive
Heart Failure (Heart Failure) (Cardiovascular),
complete with analysis by stage of development,
drug target, mechanism of action (MoA), route of
administration (RoA) and molecule type. The guide
covers the descriptive pharmacological action of
the therapeutics, its complete research and
development history and latest news and press
releases.  
4
The Congestive Heart Failure (Heart Failure)
(Cardiovascular) pipeline guide also reviews of
key players involved in therapeutic development
for Congestive Heart Failure (Heart Failure) and
features dormant and discontinued projects. The
guide covers therapeutics under Development by
Companies /Universities /Institutes, the
molecules developed by Companies in
Pre-Registration, Phase III, Phase II, Phase I,
IND/CTA Filed, Preclinical, Discovery and Unknown
stages are 2, 14, 28, 19, 3, 49, 13 and 1
respectively. Similarly, the Universities
portfolio in Phase I, Preclinical and Discovery
stages comprises 1, 21 and 4 molecules,
respectively.
5
Congestive Heart Failure (Heart Failure)
(Cardiovascular) pipeline guide helps in
identifying and tracking emerging players in the
market and their portfolios, enhances decision
making capabilities and helps to create effective
counter strategies to gain competitive advantage.
The guide is built using data and information
sourced from Global Markets Direct's proprietary
databases, company/university websites, clinical
trial registries, conferences, SEC filings,
investor presentations and featured press
releases from company/university sites and
industry-specific third party sources.
Additionally, various dynamic tracking processes
ensure that the most recent developments are
captured on a real time basis.
6
Key Topics Covered in this Report Congestive
Heart Failure Pipeline Market Research
Report Congestive Heart Failure Pipeline Market
Industry Analysis Congestive Heart Failure
Pipeline Market Volume Sales Congestive Heart
Failure Pipeline Market Revenue Congestive Heart
Failure Pipeline Market Analysis Congestive Heart
Failure Pipeline Sector Forecast Congestive Heart
Failure Pipeline Industry Competition Congestive
Heart Failure Pipeline Industry Future
Outlook Congestive Heart Failure Pipeline
Industry Trends
7
To know more, click on the link
below https//www.kenresearch.com/healthcare/gene
ral-healthcare/congestive-heart-failure-pipeline-r
eview/143894-91.html Contact UsKen
ResearchAnkur Gupta, Head Marketing
CommunicationsAnkur_at_kenresearch.com91-901537824
9
8
(No Transcript)